Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NexImmune, Inc.

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From NexImmune, Inc.
Via GlobeNewswire
Tickers NEXI
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From NexImmune, Inc.
Via GlobeNewswire
Tickers NEXI
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
From NexImmune, Inc.
Via GlobeNewswire
Tickers NEXI
NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
From NexImmune, Inc.
Via GlobeNewswire
Tickers NEXI
NexImmune Announces 1-for-25 Reverse Stock Split
From NexImmune, Inc.
Via GlobeNewswire
Tickers NEXI
NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy
From NexImmune, Inc.
Via GlobeNewswire
Tickers NEXI
NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
From NexImmune, Inc.
Via GlobeNewswire
Tickers NEXI
NexImmune Reports First Quarter 2023 Financial Results and Provides Business Updates
From NexImmune, Inc.
Via GlobeNewswire
Tickers NEXI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.